Drugs@FDA document
TECENTRIQ HYBREZA Label · BLA 761347 SUPPL-8
Drugs@FDA document · GENENTECH INC · May 19, 2026
Key facts
| Drug name | TECENTRIQ HYBREZA |
|---|---|
| Document type | Label |
| Application | BLA761347 |
| Submission | SUPPL-8 |
| Company | GENENTECH INC |
| Document date | May 19, 2026 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-New Indication Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: